Barclays upgraded LivaNova stock to Strong Buy

Published on 10/15/2026 at 13:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue hit USD 390.59 million, up 10.80 percent year over year. LivaNova stock costs EUR 68.00 on October 15, 2026.

Barclays rating and November results

Barclays upgraded LivaNova to Strong Buy on October 8, 2026.
Second-quarter 2026 revenue rose 10.80 percent year over year to USD 390.59 million.
LivaNova stock traded at EUR 68.00 at 1:46 p.m. CEST at Lang & Schwarz on October 15, 2026.
Third-quarter results are scheduled for November 4, 2026, before the market opens.

LIVN, GB00BYMT0J19, Illustration mit AI erstellt.

LivaNova PLC (ISIN GB00BYMT0J19) traded at EUR 68.00 at Lang & Schwarz on October 15, 2026, while Barclays had upgraded the stock to Strong Buy on October 8, 2026. The rating adds a fresh analyst signal ahead of the company's next quarterly report.

Barclays raises the rating

According to MarketBeat on October 8, 2026, Barclays upgraded LivaNova to Strong Buy. The report also listed an average analyst price target of USD 87.75, with six Buy ratings, one Strong Buy rating and four Hold ratings.

The rating follows a second quarter that delivered USD 390.59 million in revenue, up 10.80 percent from the second quarter of 2025. Adjusted earnings per share reached USD 1.26, versus USD 1.05 a year earlier, although the quarter benefited from a USD 6 million net tariff refund, according to the Yahoo Finance transcript dated August 5, 2026.

Growth comes with higher investment

LivaNova raised its full-year 2026 revenue-growth guidance to 8 percent to 9 percent from 7 percent to 8 percent. The company also guided to adjusted diluted earnings per share of USD 4.30 to USD 4.40, while adjusted free cash flow guidance fell to USD 140 million to USD 160 million from USD 160 million to USD 180 million as capacity and technology investments increased.

What comes next for the company?

The next scheduled milestone is LivaNova's third-quarter 2026 report on November 4, 2026, before the market opens. The conference call is scheduled for 8:00 a.m. ET, according to MarketBeat. Consensus estimates on that page call for USD 1.06 in earnings per share and USD 381.10 million in revenue.

Stock price and investor context

On the Nasdaq, LivaNova closed at USD 76.08 on October 14, 2026. The company operates in medical devices, with Cardiopulmonary and Neuromodulation among its principal businesses; its second-quarter revenue and raised annual outlook point to stronger operating performance, while the lower cash-flow guidance highlights the cost of expansion.

LivaNova was trading at EUR 68.00 at Lang & Schwarz on October 15, 2026 at 1:46 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of LivaNova stock.